|
AMD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.46400685913295E-12 |
| Normal-vs-Stage2 |
1.01589958667603E-10 |
| Normal-vs-Stage3 |
2.95999891264387E-11 |
| Normal-vs-Stage4 |
5.37940003653148E-09 |
| Stage1-vs-Stage2 |
6.366800E-01 |
| Stage1-vs-Stage3 |
8.293200E-01 |
| Stage1-vs-Stage4 |
4.401600E-01 |
| Stage2-vs-Stage3 |
7.876000E-01 |
| Stage2-vs-Stage4 |
7.557200E-01 |
| Stage3-vs-Stage4 |
5.954200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
5.024400E-04 |
| Normal-vs-Asian |
1.73549999999967E-05 |
| Caucasian-vs-AfricanAmerican |
1.387440E-01 |
| Caucasian-vs-Asian |
9.605800E-01 |
| AfricanAmerican-vs-Asian |
6.510200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.21439541650648E-11 |
| Male-vs-Female |
1.176840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.762690E-03 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
4.68609595571934E-11 |
| Normal-vs-Extreme_Obese |
4.586700019793E-09 |
| Normal_Weight-vs-Extreme_Weight |
2.409000E-01 |
| Normal_Weight-vs-Obese |
8.409200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.659000E-01 |
| Extreme_Weight-vs-Obese |
2.598200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.751400E-01 |
| Obese-vs-Extreme_Obese |
4.015200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.06989994641538E-09 |
| Normal-vs-Age(41-60Yrs) |
1.64046554118613E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64268598723538E-12 |
| Normal-vs-Age(81-100Yrs) |
7.09250436159437E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.804600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.692000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.382580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.361400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.134820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.435600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
2.73148170748527E-12 |
| Normal-VS-KIRP CIMP |
2.93129999995312E-06 |
| Normal-VS-Unclassified PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.499200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.437700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.010000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.155200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.257820E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.967980E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70641278884887E-12 |
| Normal-vs-N1 |
5.27300425545718E-11 |
| Normal-vs-N2 |
2.46070000042842E-07 |
| N0-vs-N1 |
1.267790E-01 |
| N0-vs-N2 |
4.579800E-01 |
| N1-vs-N2 |
3.790100E-02 |
|
|
